Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 8/20 | 0.41 |
| ▸ | CES1 | P23141 | 5/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL457766 | 0.89 | FAAH (0.50) | DNM1FAAHCES1CES2MEN1 | |
| SCHEMBL457735 | 0.89 | FAAH (0.50) | DNM1FAAHCES1CES2MEN1 | |
| Hydrochloric Acid SCHEMBL17294134 | 0.88 | FAAH (0.48) | DNM1FAAHCES1CES2MEN1 | |
| Sulfuric Acid SCHEMBL28748106 | 0.83 | FAAH (0.44) | DNM1FAAHCES1CES2MEN1 | |
| Sulfuric Acid SCHEMBL28412567 | 0.83 | FAAH (0.44) | DNM1FAAHCES1CES2MEN1 | |
| SCHEMBL16515965 | 0.79 | APAF1 (0.46) | DNM1APAF1HSP90AA1RAD52FAAH | |
| SCHEMBL28498503 | 0.78 | FAAH (0.40) | DNM1FAAHCES1CES2MEN1 | |
| Sulfuric Acid SCHEMBL28836715 | 0.76 | FAAH (0.52) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL2410991 | 0.72 | FAAH (0.53) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL455073 | 0.72 | FAAH (0.53) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10722449-B2 | Cosmetic composition comprising amino silicones, cationic surfactants and specific esters and a process for a cosmetic treatment | L'OREAL (FR) | 2020-07-28 | — | — | US | disclosed |
| EP-3035907-B1 | COSMETIC COMPOSITION COMPRISING AMINO SILICONES, CATIONIC SURFACTANTS AND SPECIFIC ESTERS AND A PROCESS FOR A COSMETIC TREATMENT | OREAL (FR) | 2019-04-03 | — | — | EP | disclosed |
| US-20160193136-A1 | COSMETIC COMPOSITION COMPRISING AMINO SILICONES, CATIONIC SURFACTANTS AND SPECIFIC ESTERS AND A PROCESS FOR A COSMETIC TREATMENT | L'OREAL (FR) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160193136-A1 | COSMETIC COMPOSITION COMPRISING AMINO SILICONES, CATIONIC SURFACTANTS AND SPECIFIC ESTERS AND A PROCESS FOR A COSMETIC TREATMENT | KRT18, CUTA, LAGE3 | DNM1 4398/4885APAF1 4713/4885HSP90AA1 3030/4885 |
| US-10722449-B2 | Cosmetic composition comprising amino silicones, cationic surfactants and specific esters and a process for a cosmetic treatment | KRT18, CUTA, LAGE3 | DNM1 4398/4885APAF1 4713/4885HSP90AA1 3030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.